Stay updated on Avelumab in Chemo-resistant GTN Clinical Trial
Sign up to get notified when there's something new on the Avelumab in Chemo-resistant GTN Clinical Trial page.

Latest updates to the Avelumab in Chemo-resistant GTN Clinical Trial page
- Check2 days agoChange DetectedThe page shows a revision update from v3.6.0 to v3.6.2. This indicates a minor update to the page template or metadata and does not change the study content.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe study page now indicates that enrollment is complete, and it adds new help and navigation resources to assist users in understanding and potentially joining a study; minor label formatting and a revision note were also updated.SummaryDifference0.4%

- Check23 days agoChange DetectedThe page revision label changed from v3.5.4 to v3.5.5. This appears to be a minor maintenance update and does not alter the study content or results.SummaryDifference0.1%

- Check45 days agoChange DetectedThe site revision label was updated from v3.5.3 to v3.5.4, indicating a new release of the page UI. This update does not modify the study content, eligibility criteria, locations, or outcomes shown.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page’s displayed revision/version was updated from v3.5.2 to v3.5.3, reflecting a change to the site’s interface/versioning rather than the underlying clinical trial information.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Avelumab in Chemo-resistant GTN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab in Chemo-resistant GTN Clinical Trial page.